Learn / SYRE
NASDAQ: SYRE
Spyre Therapeutics (SYRE) stock, explained like you're 5
Spyre Therapeutics trades on the Nasdaq under the ticker SYRE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 7.6 billion dollars.
- Ticker
- SYRE
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 7.6 billion dollars
Is Spyre Therapeutics a small, medium or large cap company?
No. Spyre Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 7.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Spyre Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves SYRE stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Spyre Therapeutics stock falls on public offering launch (Yahoo Finance)
- Spyre Therapeutics (SYRE) Completes $350 Million Equity Offering, Is It Still A Bargain? (Simply Wall Street)
- Spyre Therapeutics (SYRE) Poised for Growth with Promising IBD Therapies (GuruFocus)
- (SYRE) Movement Within Algorithmic Entry Frameworks (Stock Traders Daily)
- Why is Spyre Therapeutics stock rallying today? (Investing.com)
Follow SYRE in your daily brief
Each trading day at 5 PM ET we post what happened to Spyre Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow SYRE
Questions about Spyre Therapeutics stock
What does Spyre Therapeutics do?
Spyre Therapeutics trades on the Nasdaq under the ticker SYRE. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 7.6 billion dollars.
What is the ticker symbol for Spyre Therapeutics?
Spyre Therapeutics trades under the ticker SYRE on the Nasdaq.
What is Spyre Therapeutics's market cap?
Spyre Therapeutics is a mid cap stock with a market cap of about 7.6 billion dollars.
How does Spyre Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves SYRE stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow SYRE stock every day?
Add SYRE to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.